ArticleThe American journal of drug and alcohol abuse2016
Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014.
Article in The American journal of drug and alcohol abuse, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 81 citations in OpenAlex.
- Assessing self-reported use of new psychoactive substances: The impact of gate questions.The American journal of drug and alcohol abuse · 2017Trial
- Characteristics of poisonings involving ketamine in the United States, 2019-2021.Journal of psychopharmacology (Oxford, England) · 2023Article
- The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides.Psychopharmacology · 2022Article
- New psychoactive substances (NPS) in the Netherlands: occurrence in forensic drug samples, consumer drug samples and poisons center exposures between 2013 and 2017.Addiction (Abingdon, England) · 2020Observational
- Article
- Changes of clinical symptoms in patients with new psychoactive substance (NPS)-related disorders from fiscal year 2012 to 2014: A study in hospitals specializing in the treatment of addiction.Neuropsychopharmacology reports · 2019Article
- Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017.Human psychopharmacology · 2019Article
- The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.Neuropsychopharmacology reports · 2018Article
- Psychotic due to bath salts and methamphetamines: emergency cesarean section under general anesthesia.Journal of biomedical research · 2018Article
- Drugs of Abuse and Novel Psychoactive Substances at Outdoor Music Festivals in Colorado.Substance use & misuse · 2018Article
- Polysubstance use profiles among electronic dance music party attendees in New York City and their relation to use of new psychoactive substances.Addictive behaviors · 2018Article
- Attitudes and Beliefs About New Psychoactive Substance Use Among Electronic Dance Music Party Attendees.Substance use & misuse · 2018Article
- Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.Substance use & misuse · 2017Article
- Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.The American journal of drug and alcohol abuse · 2016Article
- Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.Drug and alcohol dependence · 2016Article
- Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.The American journal on addictions · 2016Article
- Synthetic cannabinoids: undesirable alternatives to natural marijuana.The American journal of drug and alcohol abuse · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundNovel psychoactive substances (NPS) are emerging at an unprecedented rate. Likewise, prevalence of use and poisonings has increased in recent years.
objectiveTo compare characteristics of NPS exposures and non-NPS-drug-related exposures and to examine whether there are differences between exposures involving synthetic cannabinoid receptor agonists (SCRAs) and other NPS.
methodsPoison control center data from the five counties of New York City and Long Island were examined from 2011-2014. We examined prevalence and characteristics of NPS exposures (classified as intentional abuse) and compared characteristics of cases involving SCRAs and other NPS.
resultsPrevalence of NPS exposures was 7.1% in 2011, rising to 12.6% in 2014. Most exposures (82.3%) involved SCRA use. The second and third most prevalent classes were phenethylamines/synthetic cathinones ("bath salts"; 10.2%) and psychedelic phenethylamines (4.3%). Compared to other drug-related exposures (i.e. involving licit and illicit drugs), those who used NPS were more likely to be younger, male, and to have not co-used other drugs (ps < 0.001). SCRA exposures increased sharply in 2014 and the mean age of users increased over time (p < 0.01). Females exposed to SCRAs were younger than males (p < 0.001), and in 2014, individuals exposed to SCRAs were more likely to report concomitant use of alcohol than users of other NPS (p = 0.010). Users of other NPS were more likely than SCRA users to report concomitant use of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)/"Molly" (p < 0.001).
conclusionExposures reported to the poison center that involve NPS are increasing and the majority involve SCRAs. These findings should inform prevention and harm reduction approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.